Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: Mineola NY, New York NY, Durham NC, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase1, Phase2, Recruiting
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06854159
Phase2, Recruiting
Efficacy of a Novel Prototype Gastrostomy Tube Anchor Dressing
for
Gastroenterology Surgery, Tube Feeding
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 7 - 21
Code: NCT07115134
Recruiting
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
for
Oral Cavity Squamous Cell Carcinoma,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07121595
Phase2, Recruiting
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
for
Fallopian Tube Carcinosarcoma,
Location: Jacksonville FL, Rochester MN, Scottsdale AZ